Hem › Idiopatisk trombocytopenisk purpura › Kalifornien
Kliniska studier för Idiopatisk trombocytopenisk purpura i Kalifornien
10 studier för Idiopatisk trombocytopenisk purpura söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
Officiell studietext (engelska)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University, Palo Alto
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- MemorialCare Long Beach Medical Center, Long Beach
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Usc Norris Comprehensive Cancer Center, Los Angeles
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- City of Hope, Duarte
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 3 sep. 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
RekryterarFas 1
Ålder 18 till 85 · Alla kön · Uppdaterad 22 juli 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
- University of Southern California (USC), Los Angeles
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Sharp Memorial Hospital, Oceanside
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 maj 2026 · NCT06544499Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.